Capula Management LTD Biomarin Pharmaceutical Inc Transaction History

Capula Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$74.43 - $92.22 $335,232 - $415,358	4,504 New	4,504 $370,000
Q4 2021 Feb 14, 2022	SELL	$71.72 - $91.47 $192,855 - $245,962	-2,689 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$74.77 - $85.47 $19,514 - $22,307	-261 Reduced 8.85%	2,689 $208,000
Q2 2021 Aug 13, 2021	BUY	$75.51 - $84.79 $222,754 - $250,130	2,950 New	2,950 $246,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

Stay updated on Capula Management LTD with notifications on news.